Zinc Supplements in Lowering Cadmium Levels in Smokers

Completed · Phase 2

Conditions studied: Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder

In brief

RATIONALE: Zinc supplements may lower cadmium levels in smokers and may help prevent DNA damage. PURPOSE: This clinical trial is studying how well zinc supplements work in lowering cadmium levels in smokers.

Key facts

Study ID

NCT00376987

Run by

Wake Forest University Health Sciences

People needed

61

Starts

2003-12-01

Expected to finish

2015-06-01

Last updated by the study team

2017-05-30

Who can join

Age: 21 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.